炎症性肠道疾病中的prokineticin系统:临床和临床前概述
Giada Amodeo1, Silvia Franchi1, Giulia Galimberti1
1Dipartimento di Scienze Farmacologiche e Biomolecolari "Rodolfo Paoletti", University of Milan, Via Vanvitelli 32, 20129 Milan, Italy.
Prokineticin 系统 (PKS) 是炎症性肠道疾病 (IBD) 的潜在治疗点,包括克罗恩病和性结肠炎. 向PKS可能会缓解与IBD相关的胃肠道症状和疼痛.
科学领域:
- 胃肠病学 胃肠病学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症性肠道疾病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),涉及慢性胃肠道炎症,有腹,出血和腹痛等异质症状.
- 疼痛是IBD的一个重要问题,即使在缓解期间也经常持续,导致生活质量下降.
- 尽管取得了进展,但IBD的病理生理学仍然不清楚,这凸显了解决消化问题和疼痛的治疗点的需要.
研究的目的:
- 审查目前关于 prokineticin 系统 (PKS) 在IBD 的参与的证据.
- 评估PKS作为IBD症状和相关疼痛的潜在治疗点.
主要方法:
- 这篇叙述性综述综合了最近临床和临床前研究的发现.
- 审查的重点是PKS在IBD病变发生的各个方面所扮演的角色.
主要成果:
- PKS的变化与多个IBD方面有关,包括肠道运动性,炎症,和疼痛.
- PKS功能障碍有助于局部腹部/内脏疼痛和中枢神经系统敏感化,导致慢性疼痛.
结论:
- Prokineticin 系统是治疗炎症性肠道疾病的有希望的,可用药物的标.
- 针对PKS可以为IBD复杂的症状提供统一的治疗策略,包括消化应急和疼痛.
更多相关视频
08:52Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
Published on: February 5, 2021
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
